Summary
Market Segment as follows:
By Type
Alpha-blocker
Phosphodiesterase Type-5 Inhibitors
5-alpha-Reductase Inhibitors
By Application
Hospitals
Clinics
Others
By Company
Astellas Pharma
Eli Lilly
GlaxoSmithKline
Sanofi
ADC Therapeutics
Bayer HealthCare
Bristol-Myers Squibb
Valeant Pharmaceuticals
Endo Pharmaceuticals
Foresee Pharmaceuticals
Madrigal Pharmaceuticals
Merck
Novartis
Spectrum Pharmaceuticals
Takeda Pharmaceuticals
Teva
Advaxis
ANI Pharmaceuticals
BHR Pharma
The main contents of the report including:
Section 1:
Product definition, type and application, global and China market overview;
Section 2:
Global and China Market competition by company;
Section 3:
Global and China sales revenue, volume and price by type;
Section 4:
Global and China sales revenue, volume and price by application;
Section 5:
China export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Interested in this report?
Get your sample now!
Table of Content
1 Market Overview
1.1 Market Segment Overview
1.1.1 Product Definition
1.1.2 Market by Type
1.1.2.1 Alpha-blocker
1.1.2.2 Phosphodiesterase Type-5 Inhibitors
1.1.2.3 5-alpha-Reductase Inhibitors
1.1.3 Market by Application
1.1.3.1 Hospitals
1.1.3.2 Clinics
1.1.3.3 Others
1.2 Global and China Market Size
1.2.1 Global Overview
1.2.2 China Overview
2 Global and China Market by Company
2.1 Global
2.1.1 Global Sales by Company
2.1.2 Global Price by Company
2.2 China
2.2.1 China Sales by Company
2.2.2 China Price by Company
3 Global and China Market by Type
3.1 Global
3.1.1 Global Sales by Type
3.1.2 Global Price by Type
3.2 China
3.2.1 China Sales by Type
3.2.2 China Price by Type
4 Global and China Market by Application
4.1 Global
4.1.1 Global Sales by Application
4.1.2 Global Price by Application
4.2 China
4.2.1 China Sales by Application
4.2.2 China Price by Application
5 China Trade
5.1 Export
5.2 Import
6 Key Manufacturers
6.1 Astellas Pharma
6.1.1 Company Information
6.1.2 Product Specifications
6.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
6.2 Eli Lilly
6.3 GlaxoSmithKline
6.4 Sanofi
6.5 ADC Therapeutics
6.6 Bayer HealthCare
6.7 Bristol-Myers Squibb
6.8 Valeant Pharmaceuticals
6.9 Endo Pharmaceuticals
6.10 Foresee Pharmaceuticals
6.11 Madrigal Pharmaceuticals
6.12 Merck
6.13 Novartis
6.14 Spectrum Pharmaceuticals
6.15 Takeda Pharmaceuticals
6.16 Teva
6.17 Advaxis
6.18 ANI Pharmaceuticals
6.19 BHR Pharma
7 Industry Upstream
7.1 Industry Chain
7.2 Raw Materials
8 Market Environment
8.1 SWOT
8.2 Porter's Five Forces
9 Conclusion
Figure Alpha-blocker Market Size and CAGR 2013-2018 (Million USD)
Figure Alpha-blocker Market Size and CAGR 2013-2018 (Volume)
Figure Alpha-blocker Market Forecast and CAGR 2019-2025 (Million USD)
Figure Alpha-blocker Market Forecast and CAGR 2019-2025 (Volume)
Figure Phosphodiesterase Type-5 Inhibitors Market Size and CAGR 2013-2018 (Million USD)
Figure Phosphodiesterase Type-5 Inhibitors Market Size and CAGR 2013-2018 (Volume)
Figure Phosphodiesterase Type-5 Inhibitors Market Forecast and CAGR 2019-2025 (Million USD)
Figure Phosphodiesterase Type-5 Inhibitors Market Forecast and CAGR 2019-2025 (Volume)
Figure 5-alpha-Reductase Inhibitors Market Size and CAGR 2013-2018 (Million USD)
Figure 5-alpha-Reductase Inhibitors Market Size and CAGR 2013-2018 (Volume)
Figure 5-alpha-Reductase Inhibitors Market Forecast and CAGR 2019-2025 (Million USD)
Figure 5-alpha-Reductase Inhibitors Market Forecast and CAGR 2019-2025 (Volume)
Figure Hospitals Market Size and CAGR 2013-2018 (Million USD)
Figure Hospitals Market Size and CAGR 2013-2018 (Volume)
Figure Hospitals Market Forecast and CAGR 2019-2025 (Million USD)
Figure Hospitals Market Forecast and CAGR 2019-2025 (Volume)
Figure Clinics Market Size and CAGR 2013-2018 (Million USD)
Figure Clinics Market Size and CAGR 2013-2018 (Volume)
Figure Clinics Market Forecast and CAGR 2019-2025 (Million USD)
Figure Clinics Market Forecast and CAGR 2019-2025 (Volume)
Figure Others Market Size and CAGR 2013-2018 (Million USD)
Figure Others Market Size and CAGR 2013-2018 (Volume)
Figure Others Market Forecast and CAGR 2019-2025 (Million USD)
Figure Others Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Volume)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2019-2025 (Million USD)
Figure Global Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2019-2025 (Volume)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Million USD)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market Size and CAGR 2013-2017 (Volume)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2019-2025 (Million USD)
Figure China Benign Prostatic Hyperplasia (BPH) Drugs Market Forecast and CAGR 2019-2025 (Volume)
Figure Global Market Sales Revenue Share by Company in 2017
Figure Global Market Sales Volume Share by Company in 2017
Figure China Market Sales Revenue Share by Company in 2017
Figure China Market Sales Volume Share by Company in 2017
Figure Global Market Sales Revenue Share by Type in 2017
Figure Global Market Sales Volume Share by Type in 2017
Figure China Market Sales Revenue Share by Type in 2017
Figure China Market Sales Volume Share by Type in 2017
Figure Global Market Sales Revenue Share by Application in 2017
Figure Global Market Sales Volume Share by Application in 2017
Figure China Market Sales Revenue Share by Application in 2017
Figure China Market Sales Volume Share by Application in 2017
Figure Industry Chain Overview
Figure Benign Prostatic Hyperplasia (BPH) Drugs SWOT List
Figure Benign Prostatic Hyperplasia (BPH) Drugs Porter's Five Forces
